López-Gómez JM - Search Results

1

Factors related with the progression of chronic kidney disease.

Yuste C, Barraca D, Aragoncillo-Sauco I, Vega-Martínez A, Abad S, Verdalles-Guzmán Ú, Ruiz-Caro C, Ampuero J, López-Gómez JM. Yuste C, et al. Nefrologia. 2013;33(5):685-91. doi: 10.3265/Nefrologia.pre2013.May.11900. Nefrologia. 2013. PMID: 24089160 Free article.

2

New expectations in the treatment of anemia in chronic kidney disease.

López-Gómez JM, Abad S, Vega A. López-Gómez JM, et al. Nefrologia. 2016 May-Jun;36(3):232-6. doi: 10.1016/j.nefro.2016.03.006. Epub 2016 Apr 29. Nefrologia. 2016. PMID: 27137103 Free article. Review. English, Spanish.

3

Assessment of nutritional status in haemodialysis patients.

Yuste C, Abad S, Vega A, Barraca D, Bucalo L, Pérez-de José A, López-Gómez JM. Yuste C, et al. Nefrologia. 2013;33(2):243-9. doi: 10.3265/Nefrologia.pre2013.Jan.11670. Nefrologia. 2013. PMID: 23511761 Free article. English, Spanish.

4

[Metabolic syndrome is associated with cardiovascular events in haemodialysis].

Pérez de José A, Verdalles-Guzmán Ú, Abad S, Vega A, Reque J, Panizo N, Rincón A, Yuste C, Arroyo D, López-Gómez JM. Pérez de José A, et al. Nefrologia. 2014;34(1):69-75. doi: 10.3265/Nefrologia.pre2013.Oct.12092. Nefrologia. 2014. PMID: 24463865 Free article. Spanish.

5

Haematuria increases progression of advanced proteinuric kidney disease.

Yuste C, Rubio-Navarro A, Barraca D, Aragoncillo I, Vega A, Abad S, Santos A, Macias N, Mahillo I, Gutiérrez E, Praga M, Egido J, López-Gómez JM, Moreno JA. Yuste C, et al. PLoS One. 2015 May 27;10(5):e0128575. doi: 10.1371/journal.pone.0128575. eCollection 2015. PLoS One. 2015. PMID: 26016848 Free PMC article.

6

Factors related to the absence of anemia in hemodialysis patients.

Verdalles U, Abad S, Vega A, Ruiz Caro C, Ampuero J, Jofre R, Lopez-Gomez JM. Verdalles U, et al. Blood Purif. 2011;32(1):69-74. doi: 10.1159/000323095. Epub 2011 Feb 24. Blood Purif. 2011. PMID: 21346339

7

Body composition affects the response to erythropoiesis-stimulating agents in patients with chronic kidney disease in dialysis.

Vega A, Ruiz C, Abad S, Quiroga B, Velázquez K, Yuste C, Aragoncillo I, López Gómez JM. Vega A, et al. Ren Fail. 2014 Aug;36(7):1073-7. doi: 10.3109/0886022X.2014.917937. Epub 2014 May 21. Ren Fail. 2014. PMID: 24846345 Free article.

8

Influence of calcium concentration in haemodialysis fluid on blood pressure control.

Ampuero Mencía J, Vega A, Abad S, Ruiz Caro C, Verdalles Ú, López Gómez JM. Ampuero Mencía J, et al. Nefrologia (Engl Ed). 2019 Jan-Feb;39(1):44-49. doi: 10.1016/j.nefro.2018.04.008. Epub 2018 Jul 31. Nefrologia (Engl Ed). 2019. PMID: 30075964 Free article. English, Spanish.

9

[Calciphylaxis: fatal complication of cardiometabolic syndrome in patients with end stage kidney disease].

Verdalles Guzmán U, de la Cueva P, Verde E, García de Vinuesa S, Goicoechea M, Mosse A, López Gómez JM, Luño J. Verdalles Guzmán U, et al. Nefrologia. 2008;28(1):32-6. Nefrologia. 2008. PMID: 18336128 Free article. Spanish.

10

The effect of replacing aluminium hydroxide with calcium acetate/magnesium carbonate on serum phosphorus control in haemodialysis patients.

Arroyo D, Panizo N, Abad S, Vega A, Pérez-de José A, López-Gómez JM. Arroyo D, et al. Nefrologia. 2014;34(2):199-204. doi: 10.3265/Nefrologia.pre2013.Nov.12145. Nefrologia. 2014. PMID: 24658194 Free article. English, Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters